Startseite
BN

Boai NKY Pharmaceuticals Ltd.

915
67
14
4.0(70)

Über das Unternehmen

  • Firmenname (rechtlich): Boai NKY Pharmaceuticals Ltd.
  • Internationaler Name: 河南博爱新开源制药有限公司 (Boai NKY Pharmaceuticals Ltd.), Boai, Henan, China
  • Marke / Handelsname: NKY
  • Registrierungsland: China
  • Adresse: Henan
Beschreibung:

Boai NKY Pharmaceuticals Ltd., founded in 1987, manufactures pharmaceutical excipients, active pharmaceutical ingredients and fine chemicals, supported by cold-storage capability, and sells to markets worldwide. In August 2010 the company was listed on the Shenzhen Stock Exchange's ChiNext board (stock code 300109). It holds its own patents, fields a professional and efficient sales team with strong technical support and application guidance, and is recognized for its brand, international approvals, experienced R&D staff, broad product line, and acceptance of both small orders and buyer-specific requirements under its own brand.

Geschäftsaktivitäten

Hilfsstoffe & Zusatzstoffe

LieferantExporteurHersteller

Pharmazeutische Wirkstoffe (API)

Hersteller

Produktionsanlagen & Betriebstechnik

Hersteller

Pharmazeutische Chemikalien

Hersteller

Unsere Produkte & Dienstleistungen

Sell · Excipients & Additives
OraRez W
Sell · Excipients & Additives
Povidone K17
Sell · Excipients & Additives
Crospovidone XL
Sell · Analytical Instruments, Lab Equipment & QC Supplies
EASTWIN® ETC821 Thermal Cycler
Sell · Excipients & Additives
KoVidone-I
Sell · Excipients & Additives
OraRez AN
Sell · Excipients & Additives
OraRez MS
Sell · Excipients & Additives
PolyKoVidone
Sell · Active Pharmaceutical Ingredients (APIs)
Povidone Iodine
Sell · Excipients & Additives
Povidone K12
Sell · Excipients & Additives
Povidone K15
Sell · Excipients & Additives
Povidone K25
Sell · Excipients & Additives
Povidone K30
Sell · Excipients & Additives
Povidone K60
Sell · Excipients & Additives
Povidone K90

Certifications

GMP certified

GMP certificate of Povidone Iodine issued by SFDA

ISO9001

Filter:
Sortieren nach:

    Keine Kommentare verfügbar.